{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,25]],"date-time":"2026-04-25T19:14:22Z","timestamp":1777144462474,"version":"3.51.4"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2011,9,9]],"date-time":"2011-09-09T00:00:00Z","timestamp":1315526400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clin Res Cardiol"],"published-print":{"date-parts":[[2011,12]]},"DOI":"10.1007\/s00392-011-0347-7","type":"journal-article","created":{"date-parts":[[2011,9,8]],"date-time":"2011-09-08T07:33:27Z","timestamp":1315467207000},"page":"1103-1109","source":"Crossref","is-referenced-by-count":32,"title":["Impact of chronic kidney disease on the prognosis of patients undergoing percutaneous coronary interventions using drug-eluting stents"],"prefix":"10.1007","volume":"100","author":[{"given":"Elif","family":"Kaya","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alessandro","family":"Cuneo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matthias","family":"Hochadel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Claus","family":"J\u00fcnger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wibke","family":"Stepper","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter","family":"Bramlage","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Karl-Heinz","family":"Kuck","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christoph A.","family":"Nienaber","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jochen","family":"Senges","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lars","family":"Eckardt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ulrich","family":"Tebbe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Holger","family":"Reinecke","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2011,9,9]]},"reference":[{"key":"347_CR1","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1056\/NEJMoa041031","volume":"351","author":"AS Go","year":"2004","unstructured":"Go AS, Chertow GM, Fan D, McCulloch CE, Hsu CY (2004) Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. N Engl J Med 351:1296\u20131305","journal-title":"N Engl J Med"},{"key":"347_CR2","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1046\/j.1523-1755.2003.00784.x","volume":"63","author":"H Reinecke","year":"2003","unstructured":"Reinecke H, Trey T, Matzkies F, Fobker M, Breithardt G, Schaefer RM (2003) Grade of chronic renal failure, and acute and long-term outcome after percutaneous coronary interventions. Kidney Int 63:696\u2013701","journal-title":"Kidney Int"},{"key":"347_CR3","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1681\/ASN.V133745","volume":"13","author":"P Muntner","year":"2002","unstructured":"Muntner P, He J, Hamm L, Loria C, Whelton PK (2002) Renal insufficiency and subsequent death resulting from cardiovascular disease in the United States. J Am Soc Nephrol 13:745\u2013753","journal-title":"J Am Soc Nephrol"},{"key":"347_CR4","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.amjcard.2004.08.089","volume":"95","author":"PA Lemos","year":"2005","unstructured":"Lemos PA, Arampatzis CA, Hove A et al (2005) Impact of baseline renal function on mortality after percutaneous coronary intervention with sirolimus-eluting stents or bare metal stents. Am J Cardiol 95:167\u2013172","journal-title":"Am J Cardiol"},{"key":"347_CR5","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1016\/j.amjcard.2005.10.018","volume":"97","author":"PK Kuchulakanti","year":"2006","unstructured":"Kuchulakanti PK, Torguson R, Chu WW et al (2006) Impact of chronic renal insufficiency on clinical outcomes in patients undergoing percutanous coronary intervention with sirolimus-eluting stents versus bare metal stents. Am J Cardiol 97:792\u2013797","journal-title":"Am J Cardiol"},{"key":"347_CR6","doi-asserted-by":"crossref","first-page":"1362","DOI":"10.1016\/j.amjcard.2009.06.058","volume":"104","author":"CA Nienaber","year":"2009","unstructured":"Nienaber CA, Akin I, Schneider S et al (2009) Clinical outcomes after sirolimus-eluting, paclitaxel-eluting and bare-metal stents in a real world setting (from the first phase of the prospective multicenter German DES.DE Registry). Am J Cardiol 104:1362\u20131369","journal-title":"Am J Cardiol"},{"key":"347_CR7","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/S0140-6736(00)02456-9","volume":"356","author":"C Baigent","year":"2000","unstructured":"Baigent C, Burbury K, Wheeler D (2000) Premature cardiovascular disease in chronic renal failure. Lancet 356:147\u2013152","journal-title":"Lancet"},{"key":"347_CR8","doi-asserted-by":"crossref","first-page":"2373","DOI":"10.1097\/01.ASN.0000083900.92829.F5","volume":"14","author":"DN Reddan","year":"2003","unstructured":"Reddan DN, Szczech LA, Tuttle RH, Shaw LK, Jones RH, Schwab SJ, Smith MS, Califf RM, Mark DB, Owen WF Jr (2003) Chronic kidney disease, mortality, and treatment strategies among patients with clinically significant coronary artery disease. J Am Soc Nephrol 14:2373\u20132380","journal-title":"J Am Soc Nephrol"},{"key":"347_CR9","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1053\/ajkd.2001.25194","volume":"38","author":"DN Reddan","year":"2001","unstructured":"Reddan DN, Marcus RJ, Owen WF Jr, Szczech LA, Landwehr DM (2001) Long-term outcomes of revascularization for peripheral vascular disease in end-stage renal disease patients. Am J Kidney Dis 38:57\u201363","journal-title":"Am J Kidney Dis"},{"key":"347_CR10","doi-asserted-by":"crossref","first-page":"2207","DOI":"10.1161\/01.CIR.0000035248.71165.EB","volume":"106","author":"CA Herzog","year":"2002","unstructured":"Herzog CA, Ma JZ, Collins AJ (2002) Comparative survival of dialysis patients in the United States after coronary angioplasty, coronary artery stenting, and coronary artery bypass surgery and impact of diabetes. Circulation 106:2207\u20132211","journal-title":"Circulation"},{"key":"347_CR11","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1016\/S0002-9149(03)00716-1","volume":"92","author":"EC Keeley","year":"2003","unstructured":"Keeley EC, Kadakia R, Soman S, Borzak S, McCullough PA (2003) Analysis of long-term survival after revascularization in patients with chronic kidney disease presenting with acute coronary syndromes. Am J Cardiol 92:509\u2013514","journal-title":"Am J Cardiol"},{"key":"347_CR12","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1053\/j.ajkd.2009.01.263","volume":"54","author":"S Yachi","year":"2009","unstructured":"Yachi S, Tanabe K, Tanimoto S et al (2009) Clinical and angiographic outcomes following percutaneous coronary intervention with sirolimus-eluting stents versus bare-metal stents in hemodialysis patients. Am J Kidney Dis 54:299\u2013306","journal-title":"Am J Kidney Dis"},{"key":"347_CR13","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1111\/j.1540-8183.2009.00524.x","volume":"23","author":"AI Syed","year":"2010","unstructured":"Syed AI, Ben-Dor I, Collins SD et al (2010) Sirolimus-eluting stent versus paclitaxel-eluting stents in patients with chronic renal insufficiency. J Inter Cardiol 23:33\u201339","journal-title":"J Inter Cardiol"},{"key":"347_CR14","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.ijcard.2007.02.026","volume":"125","author":"YH Jeong","year":"2008","unstructured":"Jeong YH, Hong MK, Lee CW et al (2008) Impact of significant chronic kidney disease on long-term clinical outcomes after drug-eluting stent versus bare metal stent implantation. Int J Cardiol 125:36\u201340","journal-title":"Int J Cardiol"},{"key":"347_CR15","first-page":"1786","volume":"44","author":"PJ Best","year":"2004","unstructured":"Best PJ, Berger PB, Davis BR et al (2004) Impact of mild or moderate chronic kidney disease on the frequency of restenosis: results from the PRESTO trial. J Am Coll Cardiol 44:1786\u20131791","journal-title":"J Am Coll Cardiol"},{"key":"347_CR16","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.ahj.2005.03.018","volume":"151","author":"DJ Blackman","year":"2006","unstructured":"Blackman DJ, Pinto R, Ross JR et al (2006) Impact of renal insufficiency on outcome after contemporary percutaneous coronary intervention. Am Heart J 151:146\u2013152","journal-title":"Am Heart J"},{"key":"347_CR17","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1016\/j.ahj.2005.01.032","volume":"150","author":"A Halkin","year":"2005","unstructured":"Halkin A, Mehran R, Casey CW et al (2005) Impact of moderate renal insufficiency on restenosis and adverse clinical events after paclitaxel-eluting and bare metal stent implantation: results from the TAXUS-IV Trial. Am Heart J 150:1163\u20131170","journal-title":"Am Heart J"},{"key":"347_CR18","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.ahj.2009.04.013","volume":"158","author":"T Ota","year":"2009","unstructured":"Ota T, Umeda H, Yokota S et al (2009) Relationship between severity of renal impairment and 2-year outcomes after sirolimus-eluting stent implantation. Am Heart J 158:92\u201398","journal-title":"Am Heart J"},{"key":"347_CR19","doi-asserted-by":"crossref","first-page":"1773","DOI":"10.1056\/NEJMoa012843","volume":"346","author":"MC Morice","year":"2002","unstructured":"Morice MC, Serruys PW, Sousa JE et al (2002) A randomized comparison of a sirolimus-eluting stent with a standard stent for coronary revascularization. N Engl J Med 346:1773\u20131780","journal-title":"N Engl J Med"},{"key":"347_CR20","doi-asserted-by":"crossref","first-page":"1610","DOI":"10.1161\/01.CIR.0000034447.02535.D5","volume":"106","author":"M Degertekin","year":"2002","unstructured":"Degertekin M, Serruys PW, Foley DP et al (2002) Persistent inhibition of neointimal hyperplasia after sirolimus-eluting stent implantation: long-term (up to 2\u00a0years) clinical, angiographic, and intravascular ultrasound follow-up. Circulation 106:1610\u20131613","journal-title":"Circulation"},{"key":"347_CR21","first-page":"41","volume":"21","author":"MS Lee","year":"2009","unstructured":"Lee MS, Canan T, Perlowski A, Bhatia R, Jurewitz D, Tobis JM (2009) Causes of death in patients undergoing percutaneous coronary intervention with drug-eluting stents in a real-world setting. J Invasive Cardiol 21:41\u2013445","journal-title":"J Invasive Cardiol"},{"key":"347_CR22","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1681\/ASN.2007111207","volume":"20","author":"H Reinecke","year":"2009","unstructured":"Reinecke H, Brand E, Mesters R et al (2009) Dilemmas in the management of atrial fibrillation in chronic kidney disease. J Am Soc Nephrol 20:705\u2013711","journal-title":"J Am Soc Nephrol"},{"issue":"4","key":"347_CR23","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1161\/CIRCINTERVENTIONS.108.828954","volume":"2","author":"CE Appleby","year":"2009","unstructured":"Appleby CE, Ivanov J, Lavi S et al (2009) The adverse long-term impact of renal impairment in patients undergoing percutaneous coronary intervention in the drug-eluting stent era. Circ Cardiovasc Interv 2(4):309\u2013316","journal-title":"Circ Cardiovasc Interv"},{"key":"347_CR24","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.jcin.2008.06.012","volume":"2","author":"F Latif","year":"2009","unstructured":"Latif F, Kleiman NS, Cohen DJ et al (2009) In-hospital and 1-year outcomes among percutaneous coronary intervention patients with chronic kidney disease in the era of drug-eluting stents: a report from the EVENT (Evaluation of Drug Eluting Stents and Ischemic Events) registry. J Am Coll Cardiol Cardiovasc Interv 2:37\u201345","journal-title":"J Am Coll Cardiol Cardiovasc Interv"},{"key":"347_CR25","doi-asserted-by":"crossref","first-page":"2458","DOI":"10.1001\/jama.2009.1800","volume":"302","author":"TT Tsai","year":"2009","unstructured":"Tsai TT, Maddox TM, Roe MT et al (2009) Contraindicated medication use in dialysis patients undergoing percutaneous coronary intervention. JAMA 302:2458\u20132464","journal-title":"JAMA"}],"container-title":["Clinical Research in Cardiology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00392-011-0347-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00392-011-0347-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00392-011-0347-7","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,12,3]],"date-time":"2021-12-03T21:51:28Z","timestamp":1638568288000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00392-011-0347-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,9,9]]},"references-count":25,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2011,12]]}},"alternative-id":["347"],"URL":"https:\/\/doi.org\/10.1007\/s00392-011-0347-7","relation":{},"ISSN":["1861-0684","1861-0692"],"issn-type":[{"value":"1861-0684","type":"print"},{"value":"1861-0692","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,9,9]]}}}